Logo
Overview
Access to Medicare rebates for assisted reproductive technology (ART) treatments in Australia is not as equal as it should be, and advocates are calling for that to change.

LGBTQIA+ couples and single parents may currently face inconsistent access to IVF rebates depending on which specialist they see, raising serious concerns about discrimination within the existing system. The issue has prompted renewed calls for updated policies that ensure all family types are treated equitably when it comes to the cost of fertility treatment.

Genea Fertility CEO Tim Yeoh and Rainbow Families Executive Officer Ashley Scott are among those leading the charge, pushing for reform that reflects the diversity of modern Australian families. Their position is clear: the pathway to parenthood should not be made harder or more expensive simply because of a person's relationship status or sexual orientation.R

For LGBTQIA+ couples, the financial burden of fertility treatment is already significant. Without consistent access to Medicare rebates, the out-of-pocket costs can be considerably higher than those faced by heterosexual couples, creating a system that is inequitable by design if not by intent.

Single women pursuing parenthood face similar challenges, with rebate eligibility varying depending on clinical interpretation of existing policy rather than a clear and consistent framework.

The call for reform is not about creating preferential treatment. It is about ensuring that the rules are applied fairly and uniformly across all patients, regardless of who they are or who they love. As fertility treatment becomes an increasingly common pathway to parenthood for a wide range of Australians, the policies governing access to financial support need to keep pace.

With advocates like Tim Yeoh and Ashley Scott raising their voices, the conversation around equitable IVF access is gaining the attention it deserves.